Vanderbilt Eye Institute Archive — Page 2 of 10

The main benefit of scleral lenses is that they can be designed to accommodate any degree of corneal steepness or irregularity.
November 13, 2023

Scleral lenses help those with corneal irregularities, dry eyes

Vanderbilt Eye Institute is one of a handful of places in Nashville that can fit patients for lenses designed to accommodate any degree of corneal steepness or irregularity.

By Nancy Humphrey
Smiling young African girl with long curly hair wearing glasses while standing alone against a gray background
August 1, 2023

VUMC participates in national study to test eye drops for nearsightedness in children

A multi-institutional study found that low-dose atropine eyedrops, commonly used in a higher dose to treat lazy eye, was no better than a placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years.

By Nancy Humphrey
Paul Sternberg Jr., MD, center, with C. Wright Pinson, MBA, MD, left, and Jeff Balser, MD, PhD, at a recent celebration honoring Sternberg’s years of service to VUMC.
June 22, 2023

Celebration honors Paul Sternberg’s decades of service

Paul Sternberg Jr., MD, was celebrated last week at a retirement ceremony honoring his 20 years of service to Vanderbilt University Medical Center as chair of the Department of Ophthalmology and Visual Sciences and founding director of the Vanderbilt Eye Institute.

By Nancy Humphrey
Lori Ann Kehler, OD, gives a low vision exam to patient Mary Elizabeth Parker at the Vanderbilt Eye Institute.
October 27, 2022

Low vision initiative for children lands new funding

Vanderbilt’s Project PAVE has received funding from the Tennessee Department of Intellectual and Developmental Disabilities to continue the program that has provided low-vision evaluations for more than 2,150 school-age children in Tennessee since 1993.

By Nancy Humphrey
October 10, 2022

Opening a window to glaucoma

A metalloprotease enzyme plays an important role in retinal ganglion cell development, Vanderbilt researchers discovered; studying it and other family members may lead to the identification of novel targets for treating glaucoma.

By Bill Snyder
The International Retinal Research Foundation Board’s Sandra Blackwood poses with Vanderbilt’s Paul Sternberg Jr., MD, left, and David Calkins, PhD.
September 22, 2022

Major commitment bolsters Vanderbilt’s retinal vision research efforts

A $10 million gift from the International Retinal Research Foundation will establish a center dedicated to retinal vision research at the Vanderbilt Eye Institute and a directorship to support a physician-scientist leader in the Department of Ophthalmology and Visual Sciences.

By Nancy Humphrey